{"id":"W4380080193","doi":"10.1002/hon.3163_108","title":"AVELUMAB MONOTHERAPY FOLLOWED BY A PET ADAPTED CHEMOTHERAPY APPROACH IN THE FIRST LINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA: INITIAL RESULTS FROM THE AVENUE WINDOW STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Avelumab; Internal medicine; Oncology; Clinical endpoint; Chemotherapy; Classical Hodgkin lymphoma; Lymphoma; Cancer; Hodgkin lymphoma; Nivolumab; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000874092,0.0005837504,0.0009201562,0.0003004731,0.0001810207,0.0005246351,0.0003712242,0.000476238,0.001992138],"category_scores_gemma":[0.0005350956,0.0002414005,0.0006313809,0.0002406039,0.0004371264,0.0006584894,0.0002440073,0.001153859,0.0003937139],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005280121,"about_ca_system_score_gemma":0.0004206169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004919164,"about_ca_topic_score_gemma":0.001074525,"domain_scores_codex":[0.9997652,0.0001209191,0.00001289057,0.00003337767,0.00002153605,0.00004607728],"domain_scores_gemma":[0.9997199,0.00007485042,0.00005266912,0.00003755189,0.00001532458,0.00009961241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3965791,0.07692748,0.02014257,0.001176748,0.001624515,0.0009494454,0.0008244157,0.003318588,0.136884,0.0005134668,0.002825658,0.3582339],"study_design_scores_gemma":[0.0859869,0.8373186,0.04860156,0.00008798585,0.0009599194,0.001525832,0.000128896,0.001782777,0.0178345,0.0002650447,0.005461682,0.0000462652],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996909,0.001699509,0.0001944184,0.0000684906,0.00001542123,0.0001535253,0.0001510071,0.00002148499,0.0007871095],"genre_scores_gemma":[0.9963966,0.001530098,0.0005613819,0.0001443917,0.00006901915,0.0001851885,0.000359828,0.00001320471,0.0007402361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001992138,"threshold_uncertainty_score":0.006664336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06510614357631912,"score_gpt":0.343084202209099,"score_spread":0.2779780586327799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}